In support of this concept, another study demonstrated that Cdc20 drives invasiveness and self-renewal in patient tumor-derived GSCs (glioblastoma stem-like cells) through pluripotenty related transcription factor SOX2 [39]. This evidence concerns the gene CDC20 and glioblastoma.